Yilong Zhou
-
- interferon and immune responses 4
- Immune Response and Inflammation 4
-
- Cancer-related molecular mechanisms research 3
- NF-κB Signaling Pathways 3
- MicroRNA in disease regulation 2
- Hepatology top 10%
-
- RNA regulation and disease 2
-
- Head and Neck Anomalies 2
-
- Obstructive Sleep Apnea Research 2
- Co-authors
- Lin WangChenxi HeBao-Xue GeBaoxue GeHaipeng LiuJianxia ChenFeng LiuYuan Zhou
- Cited by
- ImmunologyCancer ResearchHepatology
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Yilong Zhou
22 papers receiving 649 citations
Peers
Comparison fields: 5 of 97
- Immunology 187
- Cancer Research 122
- Hepatology 52
- Infectious Diseases 113
- Molecular Biology 296
Countries citing papers authored by Yilong Zhou
This map shows the geographic impact of Yilong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilong Zhou more than expected).
Fields of papers citing papers by Yilong Zhou
This network shows the impact of papers produced by Yilong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilong Zhou. The network helps show where Yilong Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yilong Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 33 | |
| 5 | 2024 | 42 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 17 | |
| 8 | 2022 | 0 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 18 | |
| 11 | 2019 | 4 | |
| 12 | 2019 | 21 | |
| 13 | 2019 | 13 | |
| 14 | 2018 | 106 | |
| 15 | 2017 | 100 | |
| 16 | 2016 | 27 | |
| 17 | 2016 | 21 | |
| 18 | 2014 | 61 | |
| 19 | Expression of leucine aminopeptidase 3 (LAP3) correlates with prognosis and malignant development of human hepatocellular carcinoma (HCC). | 2014 | 28 |
| 20 | 2013 | 96 |
About Yilong Zhou
Yilong Zhou is a scholar working on Cancer Research, Immunology and Neurology, having authored 26 papers that have together received 656 indexed citations. Recurring topics across this work include interferon and immune responses (4 papers), Immune Response and Inflammation (4 papers), Cancer-related molecular mechanisms research (3 papers), NF-κB Signaling Pathways (3 papers), Head and Neck Anomalies (2 papers), RNA regulation and disease (2 papers), Obstructive Sleep Apnea Research (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Immunology (187 citations), Cancer Research (122 citations) and Hepatology (52 citations). Yilong Zhou has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Lin Wang, Chenxi He, Bao-Xue Ge, Baoxue Ge, Haipeng Liu, Jianxia Chen, Feng Liu, Yuan Zhou, Ruijuan Zheng and Lei Liu. Their work appears in journals such as Cell, Nature Communications and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.